Clinical Benefit of High-Sensitivity KRAS Mutation Testing in Metastatic Colorectal Cancer Treated with Anti-EGFR Antibody Therapy

Tetsuo Kimura, Koichi Okamoto, Hiroshi Miyamoto, Masako Kimura, Shinji Kitamura, Hidetaka Takenaka, Naoki Muguruma, Toshiya Okahisa, Eriko Aoyagi, Mayumi Kajimoto, Yasushi Tsuji, Takahiro Kogawa, Akihito Tsuji, Tetsuji Takayama
  • Oncology, January 2012, Karger Publishers
  • DOI: 10.1159/000336792
The author haven't finished explaining this publicationThe author haven't finished explaining this publication
The following have contributed to this page: Professor (Associate) Naoki Muguruma